Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,252.20
Bid: 1,253.20
Ask: 1,253.60
Change: 9.20 (0.74%)
Spread: 0.40 (0.03%)
Open: 1,248.00
High: 1,255.60
Low: 1,221.60
Yest. Close: 1,243.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Glaxo Announces Up To GBP130M Of Investments In Africa Over The Next 5 Years

LONDON (Alliance News) - GlaxoSmithKline PLC Monday announced a series of new investments in sub-Saharan Africa of up to GBP130 million over the next five years to increase access to medicines, build its capacity and contribute to its long-term business growth. Glaxo said it plans to build

31 Mar 14 10:00

Drugmaker GSK to invest $200 mln in African factories, R&D

* Up to 100 mln pounds for new drug manufacturing in Africa * GSK looks at Rwanda, Ghana and Ethiopia for new factories * Further investment in drug R&D focused on continent By Ben Hirschler March 31 (Reuters) - Drugmaker GlaxoSmithKline plans to invest up to 130 million p

31 Mar 14 10:00

London open: Stocks at three-week high ahead of data-heavy week

- Busy week for economic data - German retail sales rise, Eurozone CPI ahead - Insurance stocks rebound after heavy falls techMARK 2,778.57 +0.59% FTSE 100 6,657.68 +0.64% FTSE 250 16,276.97 +0.59% UK stocks were trading at a three-week high on Monday morning as investors began the week in a bulli

31 Mar 14 08:29

Glaxo Heart Treatment Darapladib Misses Phase III Primary Endpoint

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that its Phase III STABILITY study for darapladib in the treatment of patients with chronic coronary heart disease failed to meet its primary endpoint, although it said that the effects of the drug on the reduction of coronary events was of

31 Mar 14 07:43

UK MORNING BRIEFING: Shares Open Higher; Polymetal Swings To Loss

LONDON (Alliance News) - Shares have opened higher Monday ahead of a week with a full calendar of economic data reports scheduled.<br /><br /><strong>Rolls-Royce</strong> Holdings PLC said it has won a deal worth more than USD50 million to support the US Marines Corps' fleet of KC-130J air-to-

31 Mar 14 07:38

GSK's darpladib study fails to meet target

GlaxoSmithKline (GSK) said the third phase of its study of darpladib failed to meet its target for the prevention of stroke. The trial randomised 15,828 patients with chronic coronary heart disease to receive 160mg of darapladib or placebo once daily. No difference was witnessed in the treatment g

31 Mar 14 07:32

UPDATE 2-Glaxo heart drug that failed trial shows potential benefit

(Adds independent doctor comment) By Bill Berkrot and Ransdell Pierson WASHINGTON, March 30 (Reuters) - A new type of heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with chronic but well-treated heart disease, showed signs of

30 Mar 14 20:59

Sunday newspaper round-up: FCA, bank competition, Glaxo

Big insurance companies want Martin Wheatley, Chief Executive of the Financial Conduct Authority, to resign after the watchdog sent their shares into freefall by making a misleading announcement about an industry probe, the Sunday Times said. The Association of British Insurers is expected to write

30 Mar 14 16:53

UPDATE 1-Glaxo heart drug that failed trial shows potential benefit

(Adds study details, researcher, Glaxo comment, background) By Bill Berkrot and Ransdell Pierson WASHINGTON, March 30 (Reuters) - A new type of heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with chronic but well-treated hear

30 Mar 14 15:32

GSK to invest in new factories and drug R&D in Africa

LONDON, March 30 (Reuters) - GlaxoSmithKline plans to make new investments in additional factories and drug research in Africa, its chief executive said on Sunday, as the pharmaceuticals group broadens its bet on promising emerging markets. Andrew Witty said the continent was important for

30 Mar 14 13:51

Study shows Glaxo heart drug which failed trial has potential benefit

WASHINGTON, March 30 (Reuters) - An experimental heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with chronic but well-treated heart disease, showed signs of potential benefit, the trial's co-leader said Sunday. The results presente

30 Mar 14 12:56

Glaxo Buys Up Rest Of Indonesian Consumer Healthcare Business

LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that it had acquired full ownership of its Indonesian Consumer Healthcare business for IDR465 billion, equivalent to GBP24.6 million, and sold its non-core brand and manufacturing facility in the country. The company bought the remain

28 Mar 14 13:49

GSK lifts emerging market bet with full control of Indonesia arm

LONDON, March 28 (Reuters) - GlaxoSmithKline is betting more on Indonesia by taking full control of its consumer healthcare unit in the country, underscoring a drive by the drugmaker to build up its presence in fast-growing emerging markets. The move, announced on Friday, mirrors the Britis

28 Mar 14 13:43

Private equity funds grab smaller slice of M&A deals

By Freya Berry LONDON, March 28 (Reuters) - Buyout firms are finding it harder to take part in mergers and acquisitions as the lure of stronger equity markets persuades more funds seeking to exit assets to try their luck with a public share sale or turn to cash-rich corporate buyers.

28 Mar 14 00:00

SW UPDATE 1-UK healthcare agency to take broader view of new drugs

* NICE to look at "wider societal impact" of new drugs * Move may mean more positive recommendations in future * NICE CEO says firms must offer NHS "very best price" * Cancer campaigners fear less money for end-of-life care (Adds further reaction from cancer charity) By

27 Mar 14 17:48

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.